Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

VIMSELTINIB vs VINBLASTINE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

VIMSELTINIB vs VINBLASTINE: Safety Overview

Metric VIMSELTINIB VINBLASTINE
Total FAERS Reports 170 5,404
Deaths Reported 0 1,018
Death Rate N/A 18.8%
Hospitalizations 5 1,653
Average Patient Age 45.6 yrs 42.2 yrs
% Female Patients 55.4% 44.5%
FDA Approval Date Feb 14, 2025 Approved Prior to Jan 1, 1982
Manufacturer Deciphera Pharmaceuticals, LLC Fresenius Kabi USA, LLC
Route ORAL INTRAVENOUS
Marketing Status Prescription Discontinued